{"schema_version":"secwatch.filing_event.v1","accession":"0001372514-23-000125","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2023-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.729845+00:00","generated_at":"2026-06-11T00:25:19.182730+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Kiora adjourns Special Meeting to Sept 27 due to lack of quorum; only 23% voted","bullets":["Special Meeting on Aug 31 lacked quorum (needed 33.3% of shares); only 23% voted.","Meeting adjourned to Sept 27, 2023 at 8:30 a.m. PT; record date remains July 18, 2023.","Company hired proxy solicitor Alliance Advisors to help obtain quorum.","Proxies already submitted will be voted at adjourned meeting unless revoked; proposals unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001372514-23-000125","json":"https://secwatch.observer/filing/0001372514-23-000125.json","markdown":"https://secwatch.observer/filing/0001372514-23-000125.md","text":"https://secwatch.observer/filing/0001372514-23-000125.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000125/0001372514-23-000125-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000125/kprx-20230831.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:25:19.182730+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}